VENUS MEDTECH-B (02500) Submits CE MDR Certification Application for Cardiovalve Transcatheter Tricuspid Valve Replacement System

Stock News

2025/12/24

VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system (Cardiovalve System) to the European Notified Body. The Cardiovalve System is a transcatheter intervention replacement product designed to treat both mitral regurgitation and tricuspid regurgitation. Compared to similar products, the Cardiovalve System's transfemoral venous approach significantly enhances treatment safety. Its large annulus design, with a maximum diameter of 55mm, is suitable for approximately 95% of the patient population. Additionally, the system's unique short-frame design effectively reduces the risk of ventricular outflow tract obstruction. The Cardiovalve System features a simple, safe, and highly reproducible operation, requiring only three steps: positioning, anchoring, and deployment.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1156767735"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156767735\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156767735?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-24 07:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156767735","market":"fut","top_or_hot":-1,"title":"VENUS MEDTECH-B (02500) Submits CE MDR Certification Application for Cardiovalve Transcatheter Tricuspid Valve Replacement System","media":"Stock News","content":"<p>VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system (Cardiovalve System) to the European Notified Body. The Cardiovalve System is a transcatheter intervention replacement product designed to treat both mitral regurgitation and tricuspid regurgitation. Compared to similar products, the Cardiovalve System's transfemoral venous approach significantly enhances treatment safety. Its large annulus design, with a maximum diameter of 55mm, is suitable for approximately 95% of the patient population. Additionally, the system's unique short-frame design effectively reduces the risk of ventricular outflow tract obstruction. The Cardiovalve System features a simple, safe, and highly reproducible operation, requiring only three steps: positioning, anchoring, and deployment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>VENUS MEDTECH-B (02500) Submits CE MDR Certification Application for Cardiovalve Transcatheter Tricuspid Valve Replacement System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVENUS MEDTECH-B (02500) Submits CE MDR Certification Application for Cardiovalve Transcatheter Tricuspid Valve Replacement System\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-24 07:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system (Cardiovalve System) to the European Notified Body. The Cardiovalve System is a transcatheter intervention replacement product designed to treat both mitral regurgitation and tricuspid regurgitation. Compared to similar products, the Cardiovalve System's transfemoral venous approach significantly enhances treatment safety. Its large annulus design, with a maximum diameter of 55mm, is suitable for approximately 95% of the patient population. Additionally, the system's unique short-frame design effectively reduces the risk of ventricular outflow tract obstruction. The Cardiovalve System features a simple, safe, and highly reproducible operation, requiring only three steps: positioning, anchoring, and deployment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1156767735","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156767735","pubTimestamp":1766531796,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","CE":"塞拉尼斯","BK4588":"碎股","BK1574":"生物医药B类股","02500":"启明医疗-B","BK4109":"特种化学制品","BK1583":"高瓴概念","BK1100":"医疗保健设备"},"translate_title":"启明医疗-B(02500)提交心瓣膜经导管三尖瓣置换系统CE MDR认证申请","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02500":1,"CE":1},"content_text":"VENUS MEDTECH-B (02500) announced that the group has recently submitted the complete application for CE MDR certification of its Cardiovalve transcatheter tricuspid valve replacement system (Cardiovalve System) to the European Notified Body. The Cardiovalve System is a transcatheter intervention replacement product designed to treat both mitral regurgitation and tricuspid regurgitation. Compared to similar products, the Cardiovalve System's transfemoral venous approach significantly enhances treatment safety. Its large annulus design, with a maximum diameter of 55mm, is suitable for approximately 95% of the patient population. Additionally, the system's unique short-frame design effectively reduces the risk of ventricular outflow tract obstruction. The Cardiovalve System features a simple, safe, and highly reproducible operation, requiring only three steps: positioning, anchoring, and deployment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}